Medicare’s $2,000 Prescription Drug Cap: A Lifeline for Millions in 2025 For millions of older Americans,the new $2,000 cap on out-of-pocket prescription drug costs under Medicare Part D is more than just a policy change—it’s a financial lifeline. According to a report released by AARP, this cap, which took effect at the start of 2025, … Read more
Medicare Part D Drug Prices Skyrocket: AARP Report Reveals Alarming Trends A new report from the AARP Public Policy Institute has uncovered a startling trend: the top 25 drugs prescribed under Medicare Part D have nearly doubled in price since their market entry, far outpacing inflation. This revelation comes as millions of Americans grapple with … Read more
Medicare Part D Drug Prices Nearly double Since Market Entry, AARP Report Finds Table of Contents Medicare Part D Drug Prices Nearly double Since Market Entry, AARP Report Finds Medicare’s New Power to Negotiate Drug Prices key Findings from the AARP Report New Protections for Medicare Beneficiaries The Human Cost of … Read more